Feng Qianhua, Zhang Yuanyuan, Zhang Wanxia, Hao Yongwei, Wang Yongchao, Zhang Hongling, Hou Lin, Zhang Zhenzhong
School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou 450001, China; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, Zhengzhou 450001, China.
School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, China.
Acta Biomater. 2017 Feb;49:402-413. doi: 10.1016/j.actbio.2016.11.035. Epub 2016 Nov 24.
In this study, an intelligent drug delivery system was developed by capping doxorubicin (DOX)-loaded hollow mesoporous CuS nanoparticles (HMCuS NPs) with superparamagnetic iron oxide nanoparticles (IONPs). Under near infrared (NIR) light irradiation, the versatile HMCuS NPs could exploit the merits of both photothermal therapy (PTT) and photodynamic therapy (PDT) simultaneously. Herein, the multifunctional IONPs as gatekeeper with the enhanced capping efficiency were supposed to realize "zero premature release" and minimize the adverse side effects during the drug delivery in vivo. More importantly, the hybrid metal nanoplatform (HMCuS/DOX@IONP-PEG) allowed several emerging exceptional characteristics. Our studies have substantiated the hybrid nanoparticles possessed an enhanced PTT effect due to coupled plasmonic resonances with an elevated heat-generating capacity. Notably, an effective removal of IONP-caps occurred after NIR-induced photo-hyperthermia via weakening of the coordination interactions between HMCuS-NH and IONPs, which suggested the feasibility of sophisticated controlled on-demand drug release upon exposing to NIR stimulus with spatial/temporal resolution. Benefiting from the favorable magnetic tumor targeting efficacy, the in vitro and in vivo experiments indicated a remarkable anti-tumor therapeutic efficacy under NIR irradiation, resulting from the synergistic combination of chemo-phototherapy. In addition, T-weighted magnetic resonance imaging (MRI) contrast performance of IONPs provided the identification of cancerous lesions. Based on these findings, the well-designed drug delivery system via integration of programmed functions will provide knowledge for advancing multimodality theranostic strategy.
As we all know, a series of shortcomings of conventional chemotherapy such as limited stability, rapid clearing and non-specific tumor targeting ability remain a significant challenge to achieve successful clinical therapeutic efficiency in cancer treatments. Fortunately, developing drug delivery system under the assistance of multifunctional nanocarries might be a great idea. For the first time, we proposed an intelligent drug delivery system by capping DOX-loaded hollow mesoporous CuS nanoparticles (HMCuS NPs) with multifunctional IONPs to integrate programmed functions including enhanced PTT effect, sophisticated controlled drug release, magnetic targeting property and MR imaging. The results showed HMCuS/DOX@IONP-PEG could significantly enhance anti-tumor therapeutic efficacy due to the synergistic combination of chemo-phototherapy. By this delicate design, we believe such smart and extreme versatile all-in-one drug delivery platform could arouse broad interests in the fields of biomaterials, nanotechnology, and drug delivery system.
在本研究中,通过用超顺磁性氧化铁纳米颗粒(IONPs)包覆负载阿霉素(DOX)的中空介孔硫化铜纳米颗粒(HMCuS NPs),开发了一种智能药物递送系统。在近红外(NIR)光照射下,多功能HMCuS NPs可以同时利用光热疗法(PTT)和光动力疗法(PDT)的优点。在此,多功能IONPs作为具有更高包覆效率的守门人,有望实现“零过早释放”,并在体内药物递送过程中最小化副作用。更重要的是,混合金属纳米平台(HMCuS/DOX@IONP-PEG)具有一些新出现的特殊特性。我们的研究证实,由于耦合等离子体共振和提高的发热能力,混合纳米颗粒具有增强的PTT效应。值得注意的是,近红外诱导的光热作用后,通过削弱HMCuS-NH与IONPs之间的配位相互作用,有效去除了IONP包覆层,这表明在近红外刺激下以空间/时间分辨率进行精确控制的按需药物释放是可行的。受益于良好的磁肿瘤靶向效果,体外和体内实验表明,在近红外照射下,由于化疗-光疗的协同作用,具有显著的抗肿瘤治疗效果。此外,IONPs的T加权磁共振成像(MRI)对比性能可用于识别癌性病变。基于这些发现,通过整合程序化功能精心设计的药物递送系统将为推进多模态诊疗策略提供知识。
众所周知,传统化疗存在一系列缺点,如稳定性有限、快速清除和非特异性肿瘤靶向能力,这仍然是在癌症治疗中实现成功临床治疗效果的重大挑战。幸运的是,在多功能纳米载体的辅助下开发药物递送系统可能是个好主意。我们首次提出了一种智能药物递送系统,通过用多功能IONPs包覆负载DOX的中空介孔硫化铜纳米颗粒(HMCuS NPs),以整合包括增强的PTT效应、精确控制的药物释放、磁靶向特性和磁共振成像在内的程序化功能。结果表明,由于化疗-光疗的协同作用,HMCuS/DOX@IONP-PEG可以显著提高抗肿瘤治疗效果。通过这种精巧的设计,我们相信这种智能且极其通用的一体化药物递送平台会在生物材料、纳米技术和药物递送系统领域引起广泛关注。